Molecular Cancer therapy: The drug Metformin suppresses the expression of PTGS2 (prostaglandin-endoperoxide synthase 2) via up regulation of its target gene, 3/February/2014, 21.39

Cancer therapy: Tumor suppressor p53 suppresses the expression of PTGS2 (prostaglandin-endoperoxide synthase 2) via up regulation of its target gene, 3/February/2014, 21.37
February 3, 2014
Tumor suppressor p53 inhibits atrial fibrillation & arrhythmia via up regulation of its target gene, 3/February/2014, 21.46
February 3, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular Cancer therapy: The drug Metformin suppresses the expression of PTGS2 (prostaglandin-endoperoxide synthase 2) via up regulation of its target gene, 3/February/2014, 21.39, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.